NCT00044525
- Conditions
- Breast Cancer, Metastatic, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Stuttgart, Baden-Wurttemberg, Germany
- Berlin, State of Berlin, Germany
- Jena, Thuringia, Germany
- Marousi, Attica, Greece
Clinical trial condition
Breast Cancer, Metastatic
Explore clinical trials studying Breast Cancer, Metastatic. Study availability and eligibility vary by location and protocol.
14 public trials
5 recruiting studies
Breast Cancer, Metastatic trial results
NCT00288249
- Conditions
- Breast Cancer, Metastatic, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Vienna, State of Vienna, Austria
- Vienna, State of Vienna, Austria
- Brasschaat, Belgium
- Plovdiv, Bulgaria
NCT01045304
- Conditions
- Breast Cancer, Metastatic, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Sanofi-Aventis Investigational Site Number 036002 Parkville, Australia
- Sanofi-Aventis Investigational Site Number 036001 Perth, Australia
- Sanofi-Aventis Investigational Site Number 036003 Westmead, Australia
- Sanofi-Aventis Investigational Site Number 056001 Brussels, Belgium
Active, Not Recruiting
Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Patients Who Achieved Durable Response to Anti-HER2 Treatment
NCT06663787
- Conditions
- Breast Cancer, Metastatic, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- Natera San Carlos, Texas, United States
- Aichi Cancer Center Nagoya, Aichi-ken, Japan
- Nagoya City University Nagoya, Aichi-ken, Japan
- The Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo, Japan